galactosamine has been researched along with mdl 201053 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolkent, S; Gezginci-Oktayoglu, S; Tunali, S; Yanardag, R | 1 |
| Bayrak, BB; Bolkent, S; Gezginci-Oktayoglu, S; Yanardag, R | 1 |
2 other study(ies) available for galactosamine and mdl 201053
| Article | Year |
|---|---|
Effects of Z-FA.FMK on D-galactosamine/tumor necrosis factor-alpha-induced kidney injury and oxidative stress in mice : effects of Z-FA.FMK on TNF-alpha-mediated kidney injury.
Topics: Animals; Antioxidants; Caspase 3; Cysteine Proteinase Inhibitors; Dipeptides; Enzyme Activation; Galactosamine; Glutathione; Immunohistochemistry; Ketones; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Proliferating Cell Nuclear Antigen; Tumor Necrosis Factor-alpha | 2008 |
Z-FA.FMK activates duodenal epithelial cell proliferation through oxidative stress, NF-kappaB and IL-1beta in D-GalN/TNF-alpha-administered mice.
Topics: Animals; Cell Proliferation; Cells, Cultured; Cysteine Proteinase Inhibitors; Dipeptides; Duodenum; Epithelial Cells; Galactosamine; Interleukin-1beta; Ketones; Liver Failure; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Oxidative Stress; Tumor Necrosis Factor-alpha | 2010 |